Literature DB >> 21836083

Proliferating reactive astrocytes are regulated by Notch-1 in the peri-infarct area after stroke.

Issei S Shimada1, Alyssa Borders, Alexander Aronshtam, Jeffrey L Spees.   

Abstract

BACKGROUND AND
PURPOSE: The formation of reactive astrocytes is common after central nervous system injuries such as stroke. However, the signaling pathway(s) that control astrocyte formation and functions are poorly defined. We assess the effects of Notch 1 signaling in peri-infarct-reactive astrocytes after stroke.
METHODS: We examined reactive astrocyte formation in the peri-infarct area 3 days after distal middle cerebral artery occlusion with or without γ-secretase inhibitor treatment. To directly study the effects of inhibiting a γ-secretase cleavage target in reactive astrocytes, we generated glial fibrillary acidic protein-CreER™:Notch 1 conditional knockout mice.
RESULTS: Gamma-secretase inhibitor treatment after stroke decreased the number of proliferative glial fibrillary acidic protein-positive reactive astrocytes and RC2-positive reactive astrocytes directly adjacent to the infarct core. The decrease in reactive astrocytes correlated with an increased number of CD45-positive cells that invaded into the peri-infarct area. To study the influence of reactive astrocytes on immune cell invasion, ex vivo immune cell invasion assays were performed. We found that a γ-secretase-mediated pathway in astrocytes affected Jurkat cell invasion. After tamoxifen treatment, glial fibrillary acidic protein-CreER™:Notch 1 conditional knockout mice had a significantly decreased number of proliferating reactive astrocytes and RC2-positive reactive astrocytes. Tamoxifen treatment also led to an increased number of CD45-positive cells that invaded the peri-infarct area.
CONCLUSIONS: Our results demonstrate that proliferating and RC2-positive reactive astrocytes are regulated by Notch 1 signal transduction and control immune cell invasion after stroke.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21836083      PMCID: PMC4469355          DOI: 10.1161/STROKEAHA.111.623280

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

Review 1.  Regeneration beyond the glial scar.

Authors:  Jerry Silver; Jared H Miller
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

2.  Notch signalling regulates stem cell numbers in vitro and in vivo.

Authors:  Andreas Androutsellis-Theotokis; Ronen R Leker; Frank Soldner; Daniel J Hoeppner; Rea Ravin; Steve W Poser; Maria A Rueger; Soo-Kyung Bae; Raja Kittappa; Ronald D G McKay
Journal:  Nature       Date:  2006-06-25       Impact factor: 49.962

Review 3.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

4.  Notch1 is required for maintenance of the reservoir of adult hippocampal stem cells.

Authors:  Jessica L Ables; Nathan A Decarolis; Madeleine A Johnson; Phillip D Rivera; Zhengliang Gao; Don C Cooper; Freddy Radtke; Jenny Hsieh; Amelia J Eisch
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

5.  Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion.

Authors:  T Nihashi; S Inao; Y Kajita; T Kawai; T Sugimoto; M Niwa; R Kabeya; N Hata; S Hayashi; J Yoshida
Journal:  Acta Neurochir (Wien)       Date:  2001       Impact factor: 2.216

6.  Linking Notch signaling to ischemic stroke.

Authors:  Joseph F Arboleda-Velasquez; Zhipeng Zhou; Hwa Kyoung Shin; Angeliki Louvi; Hyung-Hwan Kim; Sean I Savitz; James K Liao; Salvatore Salomone; Cenk Ayata; Michael A Moskowitz; Spyros Artavanis-Tsakonas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

7.  CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke.

Authors:  Benjamin Bakondi; Issei S Shimada; Anthony Perry; James R Munoz; Joni Ylostalo; Alan B Howard; Carl A Gregory; Jeffrey L Spees
Journal:  Mol Ther       Date:  2009-08-18       Impact factor: 11.454

8.  Protective role of reactive astrocytes in brain ischemia.

Authors:  Lizhen Li; Andrea Lundkvist; Daniel Andersson; Ulrika Wilhelmsson; Nobuo Nagai; Andrea C Pardo; Christina Nodin; Anders Ståhlberg; Karina Aprico; Kerstin Larsson; Takeshi Yabe; Lieve Moons; Andrew Fotheringham; Ioan Davies; Peter Carmeliet; Joan P Schwartz; Marcela Pekna; Mikael Kubista; Fredrik Blomstrand; Nicholas Maragakis; Michael Nilsson; Milos Pekny
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-29       Impact factor: 6.200

9.  Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.

Authors:  Manoj K Pandey; Bokyung Sung; Ajaikumar B Kunnumakkara; Gautam Sethi; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

10.  Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.

Authors:  N Nagai; M De Mol; H R Lijnen; P Carmeliet; D Collen
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

View more
  46 in total

1.  Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.

Authors:  Jae-Hyuk Yi; Yasuhiro Katagiri; Bala Susarla; David Figge; Aviva J Symes; Herbert M Geller
Journal:  J Comp Neurol       Date:  2012-10-15       Impact factor: 3.215

Review 2.  Glial development: the crossroads of regeneration and repair in the CNS.

Authors:  Vittorio Gallo; Benjamin Deneen
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

3.  Blocking Notch signal pathway suppresses the activation of neurotoxic A1 astrocytes after spinal cord injury.

Authors:  Dingfei Qian; Linwei Li; Yuluo Rong; Wei Liu; Qian Wang; Zheng Zhou; Changjiang Gu; Yifan Huang; Xuan Zhao; Jian Chen; Jin Fan; Guoyong Yin
Journal:  Cell Cycle       Date:  2019-09-18       Impact factor: 4.534

4.  Selective knockout of astrocytic Na+ /H+ exchanger isoform 1 reduces astrogliosis, BBB damage, infarction, and improves neurological function after ischemic stroke.

Authors:  Gulnaz Begum; Shanshan Song; Shaoxia Wang; Hanshu Zhao; Mohammad Iqbal H Bhuiyan; Eric Li; Rachel Nepomuceno; Qing Ye; Ming Sun; Michael Joseph Calderon; Donna B Stolz; Claudette St Croix; Simon C Watkins; Yinhuai Chen; Pingnian He; Gary E Shull; Dandan Sun
Journal:  Glia       Date:  2017-09-19       Impact factor: 7.452

Review 5.  Astrocyte barriers to neurotoxic inflammation.

Authors:  Michael V Sofroniew
Journal:  Nat Rev Neurosci       Date:  2015-05       Impact factor: 34.870

6.  CID1067700, a late endosome GTPase Rab7 receptor antagonist, attenuates brain atrophy, improves neurologic deficits and inhibits reactive astrogliosis in rat ischemic stroke.

Authors:  Yuan Qin; Yang He; Yong-Ming Zhu; Min Li; Yong Ni; Jin Liu; Hui-Ling Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-10-12       Impact factor: 6.150

7.  Notch1-STAT3-ETBR signaling axis controls reactive astrocyte proliferation after brain injury.

Authors:  Matthew D LeComte; Issei S Shimada; Casey Sherwin; Jeffrey L Spees
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

8.  The E3 ligase Mind bomb-1 (Mib1) modulates Delta-Notch signaling to control neurogenesis and gliogenesis in the developing spinal cord.

Authors:  Kyungjoon Kang; Donghoon Lee; Seulgi Hong; Sung-Gyoo Park; Mi-Ryoung Song
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

9.  Notch1-STAT3-ETBR signaling in brain injury and cancer.

Authors:  Matthew D LeComte; Jeffrey L Spees
Journal:  Cytokine       Date:  2015-08-25       Impact factor: 3.861

Review 10.  Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases.

Authors:  Egle Cekanaviciute; Marion S Buckwalter
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.